Boothbay Fund Management’s bluebird bio BLUE Stock Holding History

Boothbay Fund Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8	Closed	-$329K	–	1853
2021 Q1	$329K	Hold	8	–	–	0.01%	1145
2020 Q4	$472K	Buy	+8	New	+$5.07K	0.02%	775
2020 Q2	–	Sell	-7	Closed	-$427K	–	973
2020 Q1	$427K	Buy	+7	New	+$6.82K	0.04%	483
2019 Q4	–	Sell	-15	Closed	-$1.76M	–	852
2019 Q3	$1.76M	Buy	+15	New	+$22.9K	0.16%	172
2019 Q1	–	Sell	-51	Closed	-$6.51M	–	753
2018 Q4	$6.51M	Buy	+51	New	+$78.2K	0.95%	19
2018 Q3	–	Sell	-49	Closed	-$9.89M	–	796
2018 Q2	$9.89M	Buy	+49	New	+$112K	0.86%	23
2016 Q4	–	Sell	-401	Closed	-$352K	–	764
2016 Q3	$352K	Buy	+401	New	+$290K	0.08%	329
2016 Q2	–	Sell	-865	Closed	-$476K	–	510
2016 Q1	$476K	Buy	+865	New	+$531K	0.36%	76

Other funds holding BLUE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Boothbay Fund Management's BLUE Position: Q3 2023 in Review

Boothbay Fund Management sold out of bluebird bio (BLUE) in Q3 2023, closing a stake of 3,621 shares — an estimated $238K sold.

Boothbay Fund Management first reported a position in BLUE in Q4 2018 and held it in 7 quarters. The position peaked at $987K in Q4 2022. 168 funds tracked by Wall St. Rank hold BLUE as of Q3 2023.

Boothbay Fund Management reported no remaining bluebird bio position as of Q3 2023 after selling out during the quarter.
Boothbay Fund Management sold 3,621 bluebird bio shares in Q3 2023, an estimated $238K.
Boothbay Fund Management first reported a position in bluebird bio in Q4 2018 and held it in 7 quarters.
Boothbay Fund Management's bluebird bio position peaked at $987K in Q4 2022.
168 funds tracked by Wall St. Rank held bluebird bio as of Q3 2023.

Based on Boothbay Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.